Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 7, Pages e21811
Publisher
Public Library of Science (PLoS)
Online
2011-07-14
DOI
10.1371/journal.pone.0021811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors
- (2010) Chanchal Rana et al. ANNALS OF HEMATOLOGY
- GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
- (2010) M. J. Streetly et al. BLOOD
- Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs
- (2010) Fortunato Morabito et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem-repeat” lectin galectin-8
- (2010) Víctor M. Cárdenas Delgado et al. FASEB JOURNAL
- Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer
- (2010) Pratima Nangia-Makker et al. INTERNATIONAL JOURNAL OF CANCER
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
- (2010) Anna I. Markowska et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Galectin-3 Exerts Cytokine-Like Regulatory Actions through the JAK-STAT Pathway
- (2010) S.-B. Jeon et al. JOURNAL OF IMMUNOLOGY
- JS-K has potent anti-angiogenic activityin vitroand inhibits tumour angiogenesis in a multiple myeloma modelin vivo
- (2010) Tanyel Kiziltepe et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches
- (2010) Monika Engelhardt et al. LEUKEMIA & LYMPHOMA
- Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis
- (2010) Qicheng Zhao et al. Molecular Cancer
- Biological impact of vascular endothelial growth factor on vessel density and survival in multiple myeloma and plasmacytoma
- (2010) Wael M. Swelam et al. PATHOLOGY RESEARCH AND PRACTICE
- Cancer Testis Antigen Vaccination Affords Long-Term Protection in a Murine Model of Ovarian Cancer
- (2010) Maurizio Chiriva-Internati et al. PLoS One
- Galectin-3 is a substrate for prostate specific antigen (PSA) in human seminal plasma
- (2010) Sarika Saraswati et al. PROSTATE
- White Sorghum (Sorghum bicolor(L.) Moench) Bran Extracts Suppressed IgE Production by U266 Cells
- (2009) Takuya SUGAHARA et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells
- (2009) T. Hideshima et al. BLOOD
- Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma
- (2009) Michele Moschetta et al. EUROPEAN JOURNAL OF CANCER
- The targeting of the sole cyclin D1 is not adequate for mantle cell lymphoma and myeloma therapies
- (2009) G. Tchakarska et al. HAEMATOLOGICA
- Mechanism of action of lenalidomide in hematological malignancies
- (2009) Venumadhav Kotla et al. Journal of Hematology & Oncology
- Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia
- (2009) Jacob P. Laubach et al. LEUKEMIA & LYMPHOMA
- Treatment of relapsed and refractory myeloma
- (2009) Jonathan Kaufman et al. Current Hematologic Malignancy Reports
- Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis
- (2008) Won-Sik Shin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma
- (2008) J Caers et al. BRITISH JOURNAL OF CANCER
- AKAP-4: a novel cancer testis antigen for multiple myeloma
- (2008) Maurizio Chiriva-Internati et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antiangiogenesis in haematological malignancies
- (2008) William W. Li et al. BRITISH JOURNAL OF HAEMATOLOGY
- Endogenous Galectin-3 Is Localized in Membrane Lipid Rafts and Regulates Migration of Dendritic Cells
- (2008) Daniel K. Hsu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Novel anti-myeloma agents and angiogenesis
- (2008) Konstantinos Anargyrou et al. LEUKEMIA & LYMPHOMA
- Proteomic Contributions to Personalized Cancer Care
- (2008) John M. Koomen et al. MOLECULAR & CELLULAR PROTEOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More